EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
1-Year Return
22.95%
This Quarter Return
+8.79%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$5.67B
AUM Growth
+$449M
(+8.6%)
Cap. Flow
+$116M
Cap. Flow
% of AUM
2.04%
Top 10 Holdings %
Top 10 Hldgs %
21.33%
Holding
988
New
29
Increased
183
Reduced
116
Closed
41
Top Buys
| 1 |
AstraZeneca
AZN
|
$42.8M |
| 2 |
Xylem
XYL
|
$37.5M |
| 3 |
Arch Capital
ACGL
|
$36.9M |
| 4 |
Ametek
AME
|
$13.1M |
| 5 |
W.W. Grainger
GWW
|
$12.7M |
Top Sells
| 1 |
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
|
$37.3M |
| 2 |
Intuit
INTU
|
$32.4M |
| 3 |
Progressive
PGR
|
$31.2M |
| 4 |
Victoria's Secret
VSCO
|
$24.5M |
| 5 |
NVIDIA
NVDA
|
$11.1M |
Sector Composition
| 1 | Technology | 32.22% |
| 2 | Healthcare | 19.27% |
| 3 | Consumer Discretionary | 10.8% |
| 4 | Industrials | 9.16% |
| 5 | Financials | 7.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Neurocrine Biosciences
NBIX
$14.3B
| $2.25M | 0.04% |
23,800
| – | – |
|
277
Shopify
SHOP
$189B
| $2.23M | 0.04% |
35,000
| – | – |
|
278
iShares MSCI KLD 400 Social ETF
DSI
$4.79B
| $2.19M | 0.04% |
26,319
-32
| -0.1% | -$2.66K |
|
279
Acadia Pharmaceuticals
ACAD
$4.26B
| $2.17M | 0.04% |
90,600
| – | – |
|
280
T-Mobile US
TMUS
$286B
| $2.15M | 0.04% |
15,500
| – | – |
|
281
Omega Healthcare
OHI
$12.6B
| $2.14M | 0.04% |
70,165
+6,337
| +10% | +$193K |
|
282
CSX Corp
CSX
$60.2B
| $2.13M | 0.04% |
62,863
-90,765
| -59% | -$3.07M |
|
283
The Mosaic Company
MOS
$10.3B
| $2.12M | 0.04% |
61,004
-1,125
| -2% | -$39.1K |
|
284
Ionis Pharmaceuticals
IONS
$9.61B
| $2.11M | 0.04% |
51,300
| – | – |
|
285
Jones Lang LaSalle
JLL
$14.6B
| $2.1M | 0.04% |
13,629
+1,384
| +11% | +$213K |
|
286
Passage Bio
PASG
$22.3M
| $2.03M | 0.04% |
108,040
+30,000
| +38% | +$564K |
|
287
Eli Lilly
LLY
$650B
| $2.02M | 0.04% |
4,348
+885
| +26% | +$411K |
|
288
Enanta Pharmaceuticals
ENTA
$188M
| $2.01M | 0.04% |
94,500
| – | – |
|
289
PTC Therapeutics
PTCT
$4.54B
| $2M | 0.04% |
48,600
| – | – |
|
290
Medpace
MEDP
$13.7B
| $1.99M | 0.04% |
8,450
| – | – |
|
291
Amphenol
APH
$135B
| $1.96M | 0.03% |
46,080
-2,600
| -5% | -$110K |
|
292
MasTec
MTZ
$13.7B
| $1.91M | 0.03% |
16,356
+2,657
| +19% | +$310K |
|
293
eBay
EBAY
$42.3B
| $1.79M | 0.03% |
40,234
+1,000
| +3% | +$44.6K |
|
294
Tenaris
TS
$18.2B
| $1.76M | 0.03% |
60,000
| – | – |
|
295
Zscaler
ZS
$42B
| $1.73M | 0.03% |
11,955
+1,786
| +18% | +$259K |
|
296
Travelers Companies
TRV
$62.4B
| $1.69M | 0.03% |
9,900
| – | – |
|
297
Intercontinental Exchange
ICE
$99.2B
| $1.69M | 0.03% |
15,020
+4,812
| +47% | +$542K |
|
|
BPMC
298
DELISTED
Blueprint Medicines
BPMC
| $1.67M | 0.03% |
25,100
| – | – |
|
299
Halozyme
HALO
$8.58B
| $1.66M | 0.03% |
47,800
| – | – |
|
300
Annaly Capital Management
NLY
$14.1B
| $1.66M | 0.03% |
82,800
+27,200
| +49% | +$544K |
|